-
Maternal cardiac function at 35-37 weeks' gestation: relationship with birth weight.
Guy GP, Ling HZ, Machuca M, Poon LC, Nicolaides KH.
Ultrasound Obstet Gynecol 2017;49:67-72. pdf -
Maternal cardiac function at 35-37 weeks' gestation: prediction of pre-eclampsia and gestational hypertension.
Guy GP, Ling HZ, Garcia P, Poon LC, Nicolaides KH.
Ultrasound Obstet Gynecol 2017;49:61-66. pdf -
Maternal cardiovascular function at 35-37 weeks' gestation: Relation to maternal characteristics.
Guy GP, Ling HZ, Garcia P, Poon LC, Nicolaides KH.
Ultrasound Obstet Gynecol 2017;49:39-45. pdf -
First Trimester Noninvasive Prenatal Diagnosis: A Computational Intelligence Approach.
Neocleous AC, Nicolaides KH, Schizas CN.
IEEE J Biomed Health Inform 2016;20:1427-38. pdf -
Uterine artery pulsatility index in the three trimesters of pregnancy: effects of maternal characteristics and medical history.
Tayyar A, Guerra L, Wright A, Wright D, Nicolaides KH.
Ultrasound Obstet Gynecol 2015;45:689-97. pdf -
First-trimester contingent screening for trisomies 21, 18 and 13 by fetal nuchal translucency and ductus venosus flow and maternal blood cell-free DNA testing.
Kagan KO, Wright D, Nicolaides KH.
Ultrasound Obstet Gynecol 2015;45:42-7. pdf -
Fetal right ventricular contraction and relaxation times at 11-13 weeks' gestation by speckle tracking imaging.
Persico N, Fabietti I, Baffero G, Fedele L, Nicolaides KH.
Ultrasound Obstet Gynecol 2014;43:284-90. pdf -
First-trimester screening for trisomies 21, 18 and 13 by ultrasound and biochemical testing.
Wright D, Syngelaki A, Bradbury I, Akolekar R, Nicolaides KH.
Fetal Diagn Ther 2014;35:118-26. pdf -
First-trimester contingent screening for trisomy 21 by biomarkers and maternal blood cell-free DNA testing.
Nicolaides KH, Wright D, Poon LC, Syngelaki A, Gil MM.
Ultrasound Obstet Gynecol 2013;42:41-50. pdf -
First-trimester contingent screening for trisomies 21, 18 and 13 by biomarkers and maternal blood cell-free DNA testing.
Nicolaides KH, Syngelaki A, Poon LC, Gil M, Wright D.
Fetal Diagn Ther 2014;35:185-92. pdf -
Screening at 11-13+6 weeks' gestation.
Sonek JD, Nicolaides KH, Janku P.
Ceska Gynekol 2012;77:92-104. -
A mixture model of ductus venosus pulsatility index in screening for aneuploidies at 11-13 weeks' gestation.
Maiz N, Wright D, Ferreira AF, Syngelaki A, Nicolaides KH.
Fetal Diagn Ther 2012;31:221-9. -
The duration of persistent abnormal ductus venosus flow and its impact on perinatal outcome in fetal growth restriction.
Turan OM, Turan S, Berg C, Gembruch U, Nicolaides KH, Harman CR, Baschat AA.
Ultrasound Obstet Gynecol 2011;38:295-302. -
Prevalence and Outcome of Absence of Ductus Venosus at 11 to 13(+6) Weeks.
Staboulidou I, Pereira S, Cruz JJ, Syngelaki A, Nicolaides KH.
Fetal Diagn Ther 2011;30:35-40. -
Screening for fetal aneuploidies at 11 to 13 weeks.
Nicolaides KH.
Prenat Diagn 2011;31:7-15. -
Ductus venosus flow at 11-13 weeks in the prediction of birth weight discordance in monochorionic twins.
Matias A, Maiz N, Montenegro N, Nicolaides K.
J Perinat Med 2011;39:467-70. -
Contribution of ductus venosus doppler in first-trimester screening for major cardiac defects.
Chelemen T, Syngelaki A, Maiz N, Allan L, Nicolaides KH.
Fetal Diagn Ther 2011;29:127-34. -
Additional first-trimester ultrasound markers.
Sonek J, Nicolaides K.
Clin Lab Med 2010;30:573-92. -
Ductus venosus Doppler in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation.
Maiz N, Valencia C, Kagan KO, Wright D, Nicolaides KH.
Ultrasound Obstet Gynecol 2009;33:512-7. -
Learning curve for Doppler assessment of ductus venosus flow at 11 + 0 to 13 + 6 weeks' gestation.
Maiz N, Kagan KO, Milovanovic Z, Celik E, Nicolaides KH.
Ultrasound Obstet Gynecol 2008;31:503-6.